Adoptive Cell Therapy for Solid Tumors: Current Status in Melanoma and Next-Generation Therapies.
John B A G HaanenChristy LosGiao Q PhanAllison Betof WarnerPublished in: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting (2024)
Lifileucel or TIL has recently been FDA approved for metastatic melanoma patients as first cell therapy for a solid tumor. We discuss roll-out of TIL as new SOC and other upcoming new cell therapies.